Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR FR-.ALPHA. (FOLATE RECEPTOR .ALPHA.)) (HUMAN-MOUSE MONOCLONAL MORAB-003 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL MORAB-003 .KAPPA.-CHAIN, DIMER

Ovarian Cancer

Eisai Inc.monoclonal_antibodyPhase 3Dormant
CCC
51/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
47/ 100
Competitive Position
59/ 100

Competitive context

525 Active assets in the Ovarian Cancer cohort.

Asset / SponsorPhaseRating
Tisotumab Vedotin
Seagen Inc.
Phase 2BB
TIL
Inge Marie Svane
Phase 2BB
Olaparib
Shandong University
Phase 4BB
Carboplatin
Fudan University
Phase 4BB
Irinotecan
ARCAGY/ GINECO GROUP
Phase 4BB

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN RECEPTOR FR-.ALPHA. (FOLATE RECEPTOR .ALPHA.)) (HUMAN-MOUSE MONOCLONAL MORAB-003 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL MORAB-003 .KAPPA.-CHAIN, DIMER is also rated in:

peritoneal neoplasmDormant
B
Indicative ·
56 / 100
View asset →
ovarian carcinomaDormant
CCC
Indicative ·
54 / 100
View asset →
fallopian tube cancerDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →